Genus biosystems INC:1106970 [18-043822]

Ended Purchase Order Awarded Last action

Contract number
75N91018P00555
Awardee
Awarding agency
Obligated
$57,564

Award facts

Opportunity
Contract value 100% obligated
$57,564.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Northbrook, IL 60062, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Cancer Institute awarded a purchase order to Genus Biosystems Inc. for $57,564.00 on September 17, 2018. The order, which carried no set-aside designation, covers exploration of gene expression and microRNA expression changes in tumors exposed to radiation, with and without specified treatment modalities. Work is performed in Northbrook, Illinois. The order is firm fixed price and carries an ultimate completion date of September 16, 2019.

Quick answers

Who was awarded contract 75N91018P00555?

75N91018P00555 was awarded to Genus Biosystems Inc. by National Cancer Institute (National Institutes of Health) on September 17, 2018.

How much is contract 75N91018P00555 worth?

The government has obligated $57,564 on 75N91018P00555.

Was contract 75N91018P00555 competed?

The extent of competition for 75N91018P00555 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login